Peritoneal carcinomatosis
A case of disseminated carcinomatosis of the bone marrow originating from gastric cancer 3 years after intraperitoneal chemotherapy against peritoneal carcinomatosis
... leptomeningeal carcinomatosis [4] after long-term control of peritoneal ...disseminated carcinomatosis of the bone marrow (DCBM) is known to be closely associated with disseminated intravascular ...
5
Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Carcinomatosis: Is HIPEC the Only Answer?
... with peritoneal carcinomatosis is notorious for its dismal ...of peritoneal dissemination is still controversial, the rapid downhill course is uni- ...
10
Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index
... Background: The peritoneal carcinomatosis index (PCI) can be used to quantify the tumor burden in patients with advanced ovarian cancer. The aim of the present study was to establish a predictive model for ...
7
Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis
... Peritoneal carcinomatosis (PC) is a common dissemi- nated type of gastric and ovarian cancer. It is associated with a poor prognosis with a median survival of only few months [1,2]. PC is accompanied by ...
10
Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy
... for peritoneal carcinomatosis, the majority of patients receive plati- num-containing chemotherapy in either first- or second- and third-line ...in peritoneal carcinomatosis underlines the ...
7
Prophylactic effect of hyperthermic intraperitoneal chemotherapy in patients with high risk of developing peritoneal carcinomatosis from colorectal cancer
... Based on this study, we conclude that hyperthermic intrapritoneal chemotherapy (HIPEC) following surgery has a prophylactic effect against the peritoneal carcinomatosis recurrence and that will consequently ...
7
Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer
... Abstract: Intraperitoneal chemotherapy was explored in clinical trials as a promising strategy to improve the therapeutic effects of chemotherapy. In this work, we developed a biodegradable and injectable drug-delivery ...
15
Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis
... This study evaluated the potential of selected nanovehicles in modified targeted hyperthermic intraperitoneal chemotherapy without perfusion as a novel chemotherapeutic strategy for peritoneal ...
23
Treatment of peritoneal carcinomatosis with photodynamic therapy: Systematic review of current evidence
... 72. Huang KW. Photodynamic therapy of peritoneal dissemination of hepatocellular carcinoma. European Journal of Cancer 2014; Conference : 6th Asian Oncology Summit and 10th Annual Conference of the Organisation ...
32
A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature
... coexisting peritoneal carcinomatosis and liver metastasis of colorectal origin when these are the only sites of disseminated ...had peritoneal disease compared to those who had me- tastasis in both ...
6
MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis
... Monocarboxylate transporters (MCTs) play a major role in up-regulation of glycolysis and adaptation to acidosis. However, the role of MCTs in gastric cancer (GC) is not fully understood. We investigated the potential ...
12
Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murin model of peritoneal carcinomatosis
... reduced quality of life in comparison with standard sys- temic chemotherapy [6]. Intraoperative IPC after cytore- ductive surgery is a widely used alternative which achieves good results [7-9]. However, the best method ...
8
Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
... greater than 7 hours to be associated with grade IV mor- bidity [27]. The grade III and IV morbidity rate were 27% and 14%, respectively. The perioperative mortality rate was 3%. Hansson et al. analyzed 123 patients ...
8
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
... Our data indicate that cytoreductive surgery and hyper- thermic intraperitoneal chemotherapy is feasible and associated with a reasonable morbidity rate and mortality rate in patients with peritoneal ...
7
Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy
... with peritoneal carcinomatosis from colorectal cancer [13]. Peritoneal Surface Oncology Group International (PSOGI) reached a consensus that CRS and HIPEC should be con- sidered as the standard ...
6
An unusual case of a well differentiated neuroendocrine tumour of the ileum with peritoneal carcinomatosis: a case report
... In spite of this benign behaviour of G1 NETs, we re- port a case of potentially aggressive well-differentiated G1 NET. Although the low proliferative index and mi- totic rate (Ki-67 < 1% and mitotic count 2x10 HPF), ...
7
DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy
... Patients and methods: Fifty-three patients with peritoneal carcinomatosis from ovarian cancer were enrolled. Frozen tumor tissue was dissociated by a detergent–trypsin method, and the resulting cell ...
8
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study
... The animals in the control group did not receive any active surgical treatment, and only observed for natural history of disease progression. For animals in both CRS and CRS+HIPEC groups, complete cytoreduction was ...
9
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
... Peritoneal carcinomatosis (PC) had traditionally been treated as part of palliative phase and resulted in a poor prognosis with fatal disease ...macroscopic peritoneal meta- static disease, followed ...
9
Peritoneal Carcinomatosis Targeting with Tumor Homing Peptides
... and peritoneal tumor penetration of cRGD and iRGD-targeted polyethylene glycol (PEG)-stabilized cationic liposomes in mice bearing peritoneal carcinomatosis derived from human MKN-45P gastric tumor ...
22